Polyacrylate dendrimer nanoparticles: a self‐adjuvanting vaccine delivery system M Skwarczynski, M Zaman, CN Urbani, IC Lin, Z Jia, MR Batzloff, ... Angewandte Chemie International Edition 49 (33), 5742-5745, 2010 | 214 | 2010 |
Nanovaccines and their mode of action M Zaman, MF Good, I Toth Methods 60 (3), 226-231, 2013 | 171 | 2013 |
Strategies for intranasal delivery of vaccines M Zaman, S Chandrudu, I Toth Drug delivery and translational research 3, 100-109, 2013 | 137 | 2013 |
Liposome-based delivery system for vaccine candidates: constructing an effective formulation AK Giddam, M Zaman, M Skwarczynski, I Toth Nanomedicine 7 (12), 1877-1893, 2012 | 130 | 2012 |
Liposomes as nanovaccine delivery systems K Abdul Ghaffar, A Kumar Giddam, M Zaman, M Skwarczynski, I Toth Current topics in medicinal chemistry 14 (9), 1194-1208, 2014 | 121 | 2014 |
Immunostimulation by synthetic lipopeptide-based vaccine candidates: structure-activity relationships M Zaman, I Toth Frontiers in immunology 4, 318, 2013 | 108 | 2013 |
Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine M Zaman, M Skwarczynski, JM Malcolm, CN Urbani, Z Jia, MR Batzloff, ... Nanomedicine: Nanotechnology, Biology and Medicine 7 (2), 168-173, 2011 | 94 | 2011 |
Polyacrylate-based delivery system for self-adjuvanting anticancer peptide vaccine TY Liu, WM Hussein, AK Giddam, Z Jia, JM Reiman, M Zaman, ... Journal of medicinal chemistry 58 (2), 888-896, 2015 | 69 | 2015 |
Polymer–peptide hybrids as a highly immunogenic single-dose nanovaccine AAH Ahmad Fuaad, Z Jia, M Zaman, J Hartas, ZM Ziora, IC Lin, PM Moyle, ... Nanomedicine 9 (1), 35-43, 2014 | 57 | 2014 |
Structure–activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2 M Zaman, ABM Abdel-Aal, KSM Phillipps, Y Fujita, MF Good, I Toth Vaccine 28 (10), 2243-2248, 2010 | 54 | 2010 |
Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship M Zaman, ABM Abdel-Aal, Y Fujita, KSM Phillipps, MR Batzloff, MF Good, ... PloS one 7 (1), e30146, 2012 | 53 | 2012 |
Structure–activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes M Zaman, ABM Abdel-Aal, Y Fujita, ZM Ziora, MR Batzloff, MF Good, ... Journal of Medicinal Chemistry 55 (19), 8515-8523, 2012 | 52 | 2012 |
Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity M Zaman, S Chandrudu, AK Giddam, J Reiman, M Skwarczynski, ... Nanomedicine 9 (17), 2613-2624, 2014 | 48 | 2014 |
Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based toll-like receptor 2 ligand ABM Abdel-Aal, D El-Naggar, M Zaman, M Batzloff, I Toth Journal of medicinal chemistry 55 (15), 6968-6974, 2012 | 47 | 2012 |
Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components ABM Abdel-Aal, M Zaman, Y Fujita, MR Batzloff, MF Good, I Toth Journal of medicinal chemistry 53 (22), 8041-8046, 2010 | 44 | 2010 |
Novel platform technology for modular mucosal vaccine that protects against streptococcus M Zaman, V Ozberk, EL Langshaw, V McPhun, JL Powell, ZN Phillips, ... Scientific reports 6 (1), 39274, 2016 | 35 | 2016 |
Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial M Pandey, J Powell, A Calcutt, M Zaman, ZN Phillips, MF Ho, MR Batzloff, ... Scientific reports 7 (1), 13786, 2017 | 30 | 2017 |
Lipo-peptides/saccharides in peptide vaccine delivery M Skwarczynskim, M Zaman, I Toth Academic Press/Elsevier, 2013 | 30 | 2013 |
A semi-synthetic whole parasite vaccine designed to protect against blood stage malaria AK Giddam, JM Reiman, M Zaman, M Skwarczynski, I Toth, MF Good Acta biomaterialia 44, 295-303, 2016 | 29 | 2016 |
Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response M Zaman, P Simerska, I Toth Current drug delivery 7 (2), 118-124, 2010 | 26 | 2010 |